360576-04-1

Basic information

• Product Name: 6-BROMO-2,3-DIFLUOROBENZALDEHYDE
• Synonyms: 6-BROMO-2,3-DIFLUOROBENZALDEHYDE;Benzaldehyde, 6-broMo-2,3-difluoro-
• CAS NO: 360576-04-1
• Molecular Formula: C₇H₃BrF₂O
• Molecular Weight: 221
• Product Categories: Aromatic Aldehydes & Derivatives (substituted)
• Mol File: 360576-04-1.mol
• Article Data: 11

Chemical Properties

• Melting Point: 39-43℃
• Boiling Point: 225.7°Cat760mmHg
• Flash Point: 90.3°C
• Appearance: /
• Density: 1.758g/cm³
• Vapor Pressure: 0.085mmHg at 25°C
• Refractive Index: 1.561
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• Sensitive: Air Sensitive
• CAS DataBase Reference: 6-BROMO-2,3-DIFLUOROBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BROMO-2,3-DIFLUOROBENZALDEHYDE(360576-04-1)
• EPA Substance Registry System: 6-BROMO-2,3-DIFLUOROBENZALDEHYDE(360576-04-1)

Safety Data

• Hazardous Substances Data: 360576-04-1(Hazardous Substances Data)

Usage

Uses

6-BROMO-2,3-DIFLUOROBENZALDEHYDE is a useful research chemical.

InChI:InChI=1/C7H3BrF2O/c8-5-1-2-6(9)7(10)4(5)3-11/h1-3H

Upstream product

• 348-61-8 1-bromo-3,4-difluorobenzene 
• 68-12-2 N,N-dimethyl-formamide 
• 768-66-1 2,2,6,6-tetramethyl-piperidine 
• 2591-86-8 N-Formylpiperidine 

Downstream Products

• 651326-72-6 (6-bromo-2,3-difluorophenyl)methanol 
• 1186334-63-3 4-bromo-7-fluoro-1H-indazole 
• 1207875-87-3 6-bromo-2,3-difluorobenzonitrile 
• 360576-06-3 4-bromo-7-fluorobenzo[b]thiophene-2-carboxylic acid 

Relevant articles and documents

SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING

A compound of formula (I), wherein: R1 is selected from (i) H, (ii) C3-6cycloalkyl, (iii) C3-7heterocyclyl optionally substituted with a group selected from: methyl and ester, and (iv) linear or branched C1-4alkyl optionally substituted with a group selected from: alkoxy, amino, amido, acylamido, acyloxy, alkyl carboxyl ester, alkyl carbamoyl, alkyl carbamoyl ester, phenyl, phosphonate ester, C3-7heterocyclyl optionally substituted with a group selected from methyl and oxo, and a naturally occurring amino acid, optionally N-substituted with a group selected from methyl, acetyl and boc; A1 is CRA or N; A2 is CRB or N; A3 is CRC or N; A4 is CRD or N; where no more than two of A1, A2, A3, and A4 may be N; one or two of RA, RB, RC, and RD, (if present) are selected from H, F, Cl, Br, Me, CF3, cyclopropyl, cyano, OMe, OEt, CH2OH, CH2OMe and CH2NMe2; the remainder of RA, RB, RC, and RD, (if present) are H; Y is O, NH or CH2; RY is selected from: (RYA) and (RYB).

METALLO-BETA-LACTAMASE INHIBITORS AND METHODS OF USE THEREOF

The present invention relates to metallo-β-lactamase inhibitor compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein RA, R1, and Z are as defined herein. The present invention also relates to compositions whi

(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use

The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.